Champions Oncology, Inc.
USD6.21
-0.23 (-3.50%)
CEO
Robert Brainin
IPO Date
2007-02-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$6.05
Prev. Close
$6.43
Day Low
$5.77
Day High
$6.60
52W Low
$5.50
52W High
$9.63
Market Cap
$0.09B
Volume
0.00M
| -9.0 |
| 30 Apr 2023 | FY | 45.2% | -9.9% | -115.1% | -15.5% | 1.85 | 0.90 | -12.3 |
| 30 Apr 2022 | FY | 51.9% | 1.1% | 6.0% | 1.5% | 1.04 | 1.13 | 185.0 |
| 30 Apr 2021 | FY | 47.7% | 0.9% | 4.9% | 1.3% | 1.29 | 1.13 | 389.5 |
| 30 Apr 2020 | FY | 47.1% | -6.5% | -41.0% | -10.1% | 0.74 | 1.10 | -43.7 |
| 30 Apr 2019 | FY | 47.3% | 0.5% | 5.7% | 1.1% | 0.01 | 0.99 | 804.4 |
| 30 Apr 2018 | FY | 47.9% | -7.3% | -49200.0% | -18.3% | 14.33 | 0.68 | -32.3 |
| 30 Apr 2017 | FY | 37.0% | -44.7% | -1721.0% | -85.9% | 0.16 | 0.79 | -4.1 |
| 30 Apr 2016 | FY | 22.3% | -93.4% | -4389.1% | -180.8% | 0.35 | 0.82 | -3.2 |
| 78.9 |
| 31 Jul 2025 | Q1 | 42.9% | -3.3% | -13.3% | -1.5% | 1.64 | 0.93 | -46.8 |
| 30 Apr 2025 | Q4 | 41.1% | -14.9% | -48.6% | -5.7% | 1.62 | 0.94 | -13.4 |
| 31 Jan 2025 | Q3 | 61.2% | 26.4% | 82.2% | 14.7% | 1.18 | 0.99 | 8.4 |
| 31 Oct 2024 | Q2 | 44.9% | 5.4% | 106.9% | 2.9% | 9.95 | 0.75 | 18.3 |
| 31 Jul 2024 | Q1 | 49.7% | 9.3% | -395.5% | 5.3% | -21.41 | 0.69 | 12.4 |
| 30 Apr 2024 | Q4 | 48.2% | -0.8% | 5.7% | -0.4% | -3.90 | 0.63 | -151.2 |
| 31 Jan 2024 | Q3 | 34.7% | -21.1% | 122.9% | -9.4% | -3.76 | 0.60 | -7.8 |
| 31 Oct 2023 | Q2 | 42.8% | -17.9% | -2226.9% | -7.3% | 86.56 | 0.67 | -8.9 |